Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Occupation and Health》 2012-01
Add to Favorite Get Latest Update

Effect of Ganyanling injection combined with lamivudine on curative effect and immune function of patients with chronic hepatitis B

CHEN Sun-yun,WENG Xi-ding,DENG Guo-jiong,GUO Chun-hui Infectious department,Jiangyin people's hospital,Jiangsu,214400,China  
[Objective]To study the effect of Ganyanling injection combined with lamivudine on curative effect and immune function of patients with chronic hepatitis B. [Methods]60 patients with chronic hepatitis B were randomly divided into the control group and the observation group,30 patients in each group.The control group was treated with lamivudine,and the observation group received Ganyanling injection combined with lamivudine.The therapeutic effect,levels of ALT,AST and TBIL,and immune function(CD4,CD8 and CD4/CD8) were observed in two groups after 3 months of treatment. [Results]After 3 months of treatment,the total effective rate of the observation group(96.67%) was higher than that in the control group(80.00%) significantly(P0.05).The concentrations of ALT,AST and TBIL of the observation group were significantly lower than those in the control group(P0.05).The changes of CD4,CD8 and CD4/CD8 of the observation group was significantly higher than those in the control group(P0.05). [Conclusion]Ganyanling injection combined with lamivudine can significantly increase the curative effect of chronic hepatitis B and improve the immune function of patients.
【CateGory Index】: R512.62
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
【Co-citations】
China Proceedings of conference Full-text Database 1 Hits
1 ;The study of the characteristics of hepatic pathology of 112 patients with chronic hepatitis B in immunetolerant phase[A];[C];2011
【Secondary Citations】
Chinese Journal Full-text Database 10 Hits
1 DUANMU Qian,HE Feng,WANG Zhi-sheng,WU Zhi-chun,LIU Wan-sheng(Department of Infectious Disease,First People's Hospital on Anqing,Anqing,Anhui 246003);The dependability analysis in a year of the rapid virological response in lamivudine antiviral therapy[J];Anhui Medical and Pharmaceutical Journal;2009-03
2 Tang Dongdeng,Xie Dongmei,Xu Juanjuan,et al Yongjia County Hospital of Zhejiang Province(325102);Clinical Study on Telbivudine Treating Chronic Hepatitis B[J];Journal of Zhejiang University of Traditional Chinese Medicine;2009-02
3 Yang Liuxu, Zhao Zhongfu, Liu Mingshe, et al. Postgraduate of Infection diseases in Shanxi Medical University;Predicting the Efficacy of 52-week Lamivudine Treatment by Testing Hepatitis B Virus DNA Levels at 4-week[J];Journal of Changzhi Medical College;2008-02
4 Zhu Liping,Cai Limian,Huang Yi.Department of Pharmacy,Fujian Provincial Hospital,Fuzhou 350001,China;The study of relationship between serum alanine aminotransferase level in patients with chronic hepatitis B and the therapeutic effect of lamivudine:Analysis of 105 cases[J];Fujian Medical Journal;2008-04
5 Yu Fujun1,He Shengsong2,Zhang Shuling2, et al(1 Department of infection,the first affiliated hospital of WenZhou medical college,WenZhou,325000;2 Department of infection,the affiliated union hospital of Tongji medical college, Huazhong university of science and technology,WuHan,430030);Discussion of significance of the level of IL-12 and IL-4 on lamivudine therapy[J];Jiangxi Medical Journal;2005-06
6 WANG Ya-li,MU Ren-mao,LEI Bing-jun.Center of Infectious Diseases,State Key Laboratory of Biotherapy,West China Hospital,Sichuan University,Chengdu,Sichuan 610041,China;The dependablity analysis of the early respond and drug resistance in lamivudine antiviral therapy.[J];Sichuan Medical Journal;2008-06
7 Han Bai Gui-Zhen Zhao Department of Infectious Diseases,Shengjing Hospital Affiliated to China Medical University,Shenyang 110004,Liaoning Province,China;Importance of antiviral therapy for chronic hepatitis B[J];World Chinese Journal of Digestology;2008-01
8 Lu-Jun Wang1,Peng-Fei Yue1,2,Yan-Ling Zhao1,Pei-Lie Cai3,Xu Zhou1 and Hai-Long Yuan1 1.302 Hospital of PLA and PLA Institute of Chinese Materia Medica,Beijing 100039,China;2.Key Laboratory of Modern Preparation of TCM,Ministry of Education,Nanchang 330004,China;3.HUIREN Group,Shanghai 201203,China;Preparation and study of anti-hepatitis B virus activity in vitro of oxymatrine phospholipid complex[J];中国药学(英文版);2007-02
9 ZENG Min-de MAO Yi-min YAO Guang bi Department of Gastroenterology,Renji hospital,Jiaotong University,Shanghai 200001,China;Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B in China[J];Chinese Journal of Infectious Diseases;2005-06
10 YAO Guang-bi JI Yan-yan REN Hong Shanghai Jing'an Central Hospital,Shanghai 200040,China;One year trial of entecavir for Chinese chronic hepatitis B patients failed with lamivudine therapy[J];Chinese Journal of Infectious Diseases;2006-06
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved